New Strategies in Pediatric Gliomas: Molecular Advances in Pediatric Low-Grade Gliomas as a Model
- 1 September 2013
- journal article
- Published by American Association for Cancer Research (AACR) in Clinical Cancer Research
- Vol. 19 (17) , 4553-4558
Abstract
Pediatric low-grade gliomas (pLGG) account for more brain tumors in children than any other histologic subtype. While surgery, chemotherapy and radiation remain the mainstay of upfront treatment, recent advances in molecular interrogation of pLGG have shown a small number of recurring genetic mutations in these tumors that might be exploited therapeutically. Notable findings include abnormalities in the RAS/MAP kinase pathway such as NF-1 loss or BRAF activation and mTOR activation. Recent identification of activating re-arrangements in c-MYB and MYBL1 in pediatric diffuse astrocytoma also provide candidates for therapeutic intervention. Targeting these molecularly identified pathways may allow for improved outcomes for patients as pediatric oncology moves into the era of biology-driven medicine. Clin Cancer Res; 19(17); 4553–8. ©2013 AACR.Keywords
This publication has 54 references indexed in Scilit:
- Genomic analysis of diffuse pediatric low-grade gliomas identifies recurrent oncogenic truncating rearrangements in the transcription factorMYBL1Proceedings of the National Academy of Sciences, 2013
- Paradoxical activation and RAF inhibitor resistance of BRAF protein kinase fusions characterizing pediatric astrocytomasProceedings of the National Academy of Sciences, 2013
- Cooperative interactions of BRAF V600E kinase and CDKN2A locus deficiency in pediatric malignant astrocytoma as a basis for rational therapyProceedings of the National Academy of Sciences, 2012
- Interplay among BRAF, p16, p53, and MIB1 in pediatric low-grade gliomasNeuro-Oncology, 2012
- MAPK pathway activation in pilocytic astrocytomaCellular and Molecular Life Sciences, 2011
- An integrated approach to dissecting oncogene addiction implicates a Myb-coordinated self-renewal program as essential for leukemia maintenanceGenes & Development, 2011
- PI3K/AKT pathway alterations are associated with clinically aggressive and histologically anaplastic subsets of pilocytic astrocytomaActa Neuropathologica, 2010
- Initial testing (stage 1) of AZD6244 (ARRY‐142886) by the pediatric preclinical testing programPediatric Blood & Cancer, 2010
- Poly-ICLC promotes the infiltration of effector T cells into intracranial gliomas via induction of CXCL10 in IFN-α and IFN-γ dependent mannersCancer Immunology, Immunotherapy, 2010
- Tandem Duplication Producing a Novel Oncogenic BRAF Fusion Gene Defines the Majority of Pilocytic AstrocytomasCancer Research, 2008